» Articles » PMID: 21601607

Characterizing Non-constant Relative Potency

Overview
Publisher Elsevier
Specialties Pharmacology
Toxicology
Date 2011 May 24
PMID 21601607
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Relative potency plays an important role in toxicology. Estimates of relative potency are used to rank chemicals by their effects, to calculate equivalent doses of test chemicals compared to a standard, and to weight contributions of constituent chemicals when evaluating mixtures. Typically relative potency is characterized by a constant dilution factor, even when non-similar dose-response curves indicate that constancy is inappropriate. Improperly regarding relative potency as constant may distort conclusions and potentially mislead investigators or policymakers. We consider a more general approach that allows relative potency to vary as a function of dose, response, or response quantile. Distinct functions can be defined, each generalizing different but equivalent descriptions of constant relative potency. When two chemicals have identical response limits, these functions all carry fundamentally equivalent information; otherwise, relative potency as a function of response quantile is distinct and embodies a modified definition of relative potency. Which definition is preferable depends on whether one views any differences in response limits as intrinsic to the chemicals or as extrinsic, arising from idiosyncrasies of data sources. We illustrate these ideas with constructed examples and real data. Relative potency functions offer a unified and principled description of relative potency for non-similar dose-response curves.

Citing Articles

Evaluation of the Interaction-Based Hazard Index Formula Using Data on Four Trihalomethanes from U.S. EPA's Multiple-Purpose Design Study.

Hertzberg R, Teuschler L, McDonald A, Sey Y, Simmons J Toxics. 2024; 12(5).

PMID: 38787084 PMC: 11125920. DOI: 10.3390/toxics12050305.


Complex Mixtures and Multiple Stressors: Evaluating Combined Chemical Exposures and Cumulative Toxicity.

Kassotis C, Phillips A Toxics. 2023; 11(6).

PMID: 37368587 PMC: 10303128. DOI: 10.3390/toxics11060487.


Selection for and Analysis of UV-Resistant Cryptophlebia Leucotreta Granulovirus-SA as a Biopesticide for .

Mwanza P, Jukes M, Dealtry G, Lee M, Moore S Viruses. 2022; 14(1).

PMID: 35062232 PMC: 8780862. DOI: 10.3390/v14010028.


The advantages of linear concentration-response curves for in vitro bioassays with environmental samples.

Escher B, Neale P, Villeneuve D Environ Toxicol Chem. 2018; 37(9):2273-2280.

PMID: 29846006 PMC: 6150494. DOI: 10.1002/etc.4178.


Parameterizing dose-response models to estimate relative potency functions directly.

Dinse G, Umbach D Toxicol Sci. 2012; 129(2):447-55.

PMID: 22700543 PMC: 3491959. DOI: 10.1093/toxsci/kfs209.

References
1.
Walker N, Crockett P, Nyska A, Brix A, Jokinen M, Sells D . Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds". Environ Health Perspect. 2005; 113(1):43-8. PMC: 1253708. DOI: 10.1289/ehp.7351. View

2.
Cornfield J . COMPARATIVE BIOASSAYS AND THE ROLE OF PARALLELISM. J Pharmacol Exp Ther. 1964; 144:143-9. View

3.
Putzrath R . Estimating relative potency for receptor-mediated toxicity: reevaluating the toxicity equivalence factor (TEF) model. Regul Toxicol Pharmacol. 1997; 25(1):68-78. DOI: 10.1006/rtph.1996.1063. View

4.
Cox C, Leaverton P . Statistical procedures for bioassays when the condition of similarity does not obtain. J Pharm Sci. 1966; 55(7):716-23. DOI: 10.1002/jps.2600550709. View

5.
. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 2006; (520):4-246. View